Kristen Nickens

FDA investigator

Appears on 3 documents from 2017 to 2024, most often at sites in India. Most often cites written procedures; deviations (21 CFR 211.100).

3
Documents on file
2.7
Observations per 483
2017
First seen
2024
Most recent

What they cite most

From 8 observations

Activity by year

2017: 1, 2020: 1, 2024: 1

Where

India 1 · Maryland 1 · Minnesota 1

Is Kristen Nickens coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 AstraZeneca Pharmaceuticals LP Frederick Manufacturing Cente /'Jun 7, 2024 · Frederick, Maryland
483 Takeda Pharmaceuticals U.S.A., Inc.Mar 18, 2020 · Brooklyn Park, Minnesota
483 Biocon LimitedApr 7, 2017 · Bangalore, India

About this profile

What does Kristen Nickens inspect?

Kristen Nickens appears on 3 documents on file covering 3 sites, most often in India.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.192 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Kristen Nickens is dated Jun 7, 2024.